About this trial
To establish a clinical registry of suspected cases of AFE. The existing registry will be migrated to a new platform,
Eligibility criteria
Qualifiers
All subjects or their next of kin must be able to provide a signed and dated informed consent form.
In the case of lethal AFE, the surviving family member or next of kin must be able to provide a signed and dated informed consent form with an accompanying death certificate and proof of legal kinship.
Participants are expected to be willing to permit collection of data about their affected pregnancy, previous and future pregnancies, and their current and future health conditions.
Providing biological samples is not required for enrollment.
Disqualifiers
The inability of an individual to provide a signed and dated informed consent form or those who do not wish to participate.
Trial design
Treatments tested in this trial
- Patient
Treatment groups
Sponsors and collaborators
The University of Texas Health Science Center, Houston
Lead sponsor
Amniotic Fluid Embolism (AFE) Foundation
Collaborator